The process by which T cells are activated, and the consequences of activation (e.g. new gene transcription, cytokine production, apoptosis), are being investigated by a variety of approaches: 1) studies on the roles of src family kinases (especially Lck and Fyn) in T cell function. We have found activation of Lck leads to the rapid internalization of the T cell antigen receptor (TCR) and its destruction in lysosomes. Studies to determine the molecular mechanism for this phenomenon are ongoing. 2) the possible role of phosphatidylinositol-3 kinase (PI-3 kinase) in transducing activating signals via the T cell antigen receptor (TCR). Using both pharmacologic inhibitors of PI-3 kinase activity and dominant negative forms of the PI-3 kinase p85 subunit, we have demonstrated a critical role for this enzyme in IL-2 production. 3) activation-induced apoptosis of T cell hybridomas is mediated by upregulation of the ligand for Fas (FasL). We have identified a single major site 5' of the transcription initiation site that is required for initiation of fasL transcription, and are in the process of characterizing the transcription factor(s) that bind this regulatory element. 4) we have found that corticosteroids prevent activation-induced apoptosis, and have hypothesized that this phenomenon regulates antigen-specific selection of thymocytes. We have crossed transgenic mice that express antisense glucocorticoid receptor in immature thymocytes with lpr autoimmune mice, and have found that TCR Vbeta usage is altered and autoimmunity and lymphadenopathy are greatly improved. These results demonstrate that glucocorticoids, most likely those produced in the thymus itself, do in fact regulate positive selection of thymocytes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC009290-13
Application #
6100968
Study Section
Special Emphasis Panel (LICB)
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Ashwell, Jonathan D (2006) The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol 6:532-40
Schito, Marco L; Demidov, Oleg N; Saito, Shin'ichi et al. (2006) Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation. J Immunol 176:4818-25
Wu, Chuan-Jin; Conze, Dietrich B; Li, Tao et al. (2006) Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected] Nat Cell Biol 8:398-406
Salvador, Jesus M; Mittelstadt, Paul R; Guszczynski, Tad et al. (2005) Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat Immunol 6:390-5
Mittelstadt, Paul R; Salvador, Jesus M; Fornace Jr, Albert J et al. (2005) Activating p38 MAPK: new tricks for an old kinase. Cell Cycle 4:1189-92
Wu, Chuan-Jin; Conze, Dietrich B; Li, Xiaoming et al. (2005) TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J 24:1886-98
Munitic, Ivana; Ryan, Philip E; Ashwell, Jonathan D (2005) T cells in G1 provide a memory-like response to secondary stimulation. J Immunol 174:4010-8
Salvador, Jesus M; Mittelstadt, Paul R; Belova, Galina I et al. (2005) The autoimmune suppressor Gadd45alpha inhibits the T cell alternative p38 activation pathway. Nat Immunol 6:396-402
Mittelstadt, Paul R; Ashwell, Jonathan D (2003) Disruption of glucocorticoid receptor exon 2 yields a ligand-responsive C-terminal fragment that regulates gene expression. Mol Endocrinol 17:1534-42
Rengarajan, J; Mittelstadt, P R; Mages, H W et al. (2000) Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity 12:293-300

Showing the most recent 10 out of 14 publications